Ogivri 440 mg
Ogivri 440 mg is a medicine authorised by Swissmedic under authorisation number 67470. The authorisation holder is Medius AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 02 April 2020 and the authorisation is valid without a time limit. ATC code L01FD01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 67470 |
|---|---|
| Name | Ogivri 440 mg |
| Full name | Ogivri 440 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Medius AG |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01FD01 |
| First authorisation | 02 April 2020 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Ogivri 440 mg, Pulver für ein Konzentrat zur Herstellung einer Infusionslösung | A | 02 April 2020 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01FD01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Ogivri 440 mg authorised in Switzerland?
Yes. Ogivri 440 mg is authorised by Swissmedic under authorisation number 67470, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Ogivri 440 mg have?
Ogivri 440 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Ogivri 440 mg?
The authorisation holder is Medius AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.